Robert A. Newman

University Of Texas Md Anderson Can Ctr

$3,418,666

Attributed

$3,418,666

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $395.4K · FY2005–08

$500K$375K$250K$125K$0

'05

'06

'07

'08

Funding mix

By agency

NIH$3,418,666 · 7

By mechanism

P30$1,426,986 · 1

P01$1,423,240 · 2

R21$226,500 · 1

N01$195,584 · 2

U19$146,356 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Texas Md Anderson Can Ctr

Same institution · by research overlap

Scott M Lippman$54,535,308
Jeffrey Nicholas Myers$13,165,599
Susan M Fischer$12,916,650
Stephen E Ullrich$5,147,419
Xifeng Wu$28,679,533

Others in their field

Top investigators on “Pharmacokinetics”

Leonard Freedman · Leidos Biomedical Research, Inc.$237,100,725
Constance Ann Benson · University Of California, San Diego$151,891,628
Richard L Schilsky · University Of Chicago$114,474,127
Ronald T Mitsuyasu · University Of California Los Angeles$105,970,100
Wafaa M. El-Sadr · Columbia University Health Sciences$91,574,471
Myron S Cohen · Family Health International$91,263,426

Research focus

PharmacokineticsNeoplasm /Cancer PharmacologyBiomedical FacilityMass SpectrometryHuman TissueNuclear Magnetic Resonance SpectroscopyHigh Performance Liquid ChromatographyAnalytical ChemistryRadiochemistryGas Chromatography Mass SpectrometryDrug Screening /EvaluationAnimal TissueAntineoplasticsMethod DevelopmentLaboratory MouseProstaglandin Endoperoxide SynthaseEicosanoid MetabolismPrimatesDrug MetabolismDogsAntiaids AgentDrug Administration RoutesProstaglandin EIntravenous Administration